We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pending Patent Reform Law May Nix Ranbaxy False Marking Suit
Pending Patent Reform Law May Nix Ranbaxy False Marking Suit
August 2, 2011
A federal judge has ruled that a false patent marking lawsuit against Ranbaxy Laboratories may proceed, but the generic-drug giant may win reprieve via the America Invents Act.